OCRX
Ocera Therapeutics, Inc.
OCRX
OCRX
Delisted
OCRX was delisted on the 8th of December, 2017.
36 hedge funds and large institutions have $45.1M invested in Ocera Therapeutics, Inc. in 2014 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
36
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$4.25M | |
| 2 | +$1.69M | |
| 3 | +$1.12M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$821K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$612K |
Top Sellers
| 1 | -$2.28M | |
| 2 | -$1.41M | |
| 3 | -$289K | |
| 4 |
QF
QVT Financial
New York
|
-$168K |
| 5 |
Morgan Stanley
New York
|
-$111K |